Cellectis (CLLS) Divestments (2016 - 2024)
Cellectis (CLLS) recorded quarterly Divestments of -$105.4 million in Q2 2024, down 6128.9% quarter-over-quarter from -$1.7 million in Q1 2024, and down 108552.58% on a YoY basis from N/an in Q3 2023.
Cellectis (CLLS) Divestments (2016 - 2024) Analysis & Trends
Cellectis' Divestments history runs 9 years deep, the most recent figure standing at -$105.4 million for Q2 2024.
- In Q2 2024, Divestments fell 108552.58% year-over-year to -$105.4 million; the TTM figure through Jun 2024 stood at -$107.0 million (down 36008.05% YoY), while the FY2023 annual figure was $79000.0, up 117.71% from the prior year.
- Divestments was -$105.4 million for Q2 2024 at Cellectis, down from -$1.7 million in the prior quarter.
- In the past five years, Divestments ranged from a high of $15.0 million in Q2 2021 to a low of -$105.4 million in Q2 2024.
- Historically, Divestments has averaged -$6.4 million across 5 years, with a median of $97000.0 in 2023.
- The sharpest annual moves came in 2020 and 2024: Divestments soared 862800.0% in 2020, then tumbled 108552.58% in 2024.
- A 5-year view of Divestments shows it stood at $8.1 million in 2020, then slumped by 295.07% to -$15.7 million in 2021, then soared by 100.77% to $121000.0 in 2022, then tumbled by 34.71% to $79000.0 in 2023, then tumbled by 133508.86% to -$105.4 million in 2024.
- The last three Divestments figures came in at -$105.4 million (Q2 2024), -$1.7 million (Q1 2024), and $79000.0 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -105.39 Mn |
| Mar 31, 2024 | -1.69 Mn |
| Sep 30, 2023 | 79,000.00 |
| Jun 30, 2023 | -97,000.00 |
| Mar 31, 2023 | 97,000.00 |
| Dec 31, 2022 | 121,000.00 |
| Sep 30, 2022 | 177,000.00 |
| Jun 30, 2022 | -448,000.00 |
| Mar 31, 2022 | -296,000.00 |
| Dec 31, 2021 | -15.72 Mn |
| Sep 30, 2021 | 3.00 Mn |
| Jun 30, 2021 | 15.05 Mn |
| Mar 31, 2021 | 8.65 Mn |
| Dec 31, 2020 | 8.06 Mn |
| Sep 30, 2020 | 9.14 Mn |
| Jun 30, 2020 | 8.63 Mn |
| Mar 31, 2020 | -38.62 Mn |
| Sep 30, 2019 | -20.00 Mn |
| Jun 30, 2019 | -1,000.00 |
| Mar 31, 2019 | 162,000.00 |